[1] Han I H, Kim J H, Ryu J S. Inflammatory response to
Trichomonas vaginalis in the pathogenesis of prostatitis
and benign prostatic hyperplasia[J]. Parasites, Hosts and
Diseases, 2023, 61(1): 2-14.
[2] Edwards T, Burke P, Smalley H, et al. Trichomonas
vaginalis: Clinical relevance, pathogenicity and diagnosis[J].
Critical Reviews in Microbiology, 2016, 42(3): 406-417.
[3] Durel P, Roiron V, Siboulet A, et al. Systemic treatment of
human trichomoniasis with a derivative of nitro-imidazole,
8823 RP.[J]. The British journal of venereal diseases, 1960,
36(1): 21-26.
[4] Sapkota S, Niroula A, Prajapati R, et al. Metronidazole
induced cerebellar toxicity: A case report[J]. Journal of the
Nepal Medical Association, 2021, 59(241): 922-924.
[5] Abdrabou M A, Alrashdi B M, Alruwaili H K, et al.
Exploration of Maternal and Fetal Toxicity Risks for
Metronidazole-Related Teratogenicity and Hepatotoxicity
through an Assessment in Albino Rats[J]. Toxics, 2023, 11(4): 303.
[6] Findley K, Oh J, Yang J, et al. Topographic diversity of
fungal and bacterial communities in human skin[J]. Nature,
2013, 498(7454): 367-370.
[7] Oh J, Byrd A L, Park M, et al. Temporal Stability of the
Human Skin Microbiome[J]. Cell, 2016, 165(4): 854-866.
[8] Wong R, Geyer S, Weninger W, et al. The dynamic
anatomy and patterning of skin[J]. Experimental
Dermatology, 2016, 25(2): 92-98.
[9] Jahns A C, Alexeyev O A. Three dimensional distribution
of Propionibacterium acnes biofilms in human skin[J].
Experimental Dermatology, 2014, 23(9): 687-689.
[10] Nakatsuji T, Chiang H I, Jiang S B, et al. The microbiome
extends to subepidermal compartments of normal skin[J].
Nature Communications, 2013, 4(1): 1431.
[11] Oh J, Byrd A L, Deming C, et al. Biogeography
and individuality shape function in the human skin
metagenome[J]. Nature, 2014, 514(7520): 59-64.
[12] Zhao S, Lieberman T D, Poyet M, et al. Adaptive
Evolution within Gut Microbiomes of Healthy People[J]. Cell
Host and Microbe, 2019, 25(5): 656-667.e8.
[13] Aas J A, Paster B J, Stokes L N, et al. Defining the
normal bacterial flora of the oral cavity[J]. Journal of Clinical
Microbiology, 2005, 43(11): 5721-5732.
[14] Bassis C M, Tang A L, Young V B, et al. The nasal cavity
microbiota of healthy adults[J]. Microbiome, 2014, 2(1): 27.
[15] 李可 . 妇女生殖道益生菌菌株制剂的研究 [J]. 内蒙古
医科大学 , 2019.
[16] López-Moreno A, Aguilera M. Vaginal probiotics for
reproductive health and related dysbiosis: Systematic review
and meta-analysis[J]. Journal of Clinical Medicine, 2021,
10(7): 1461.
[17] Liu B, Faller L L, Klitgord N, et al. Deep sequencing
of the oral microbiome reveals signatures of periodontal
disease[J]. PLoS ONE, 2012, 7(6): 37919.
[18] Yan M, Pamp S J, Fukuyama J, et al. Nasal
microenvironments and interspecific interactions influence
nasal microbiota complexity and S. aureus carriage[J]. Cell
Host and Microbe, 2013, 14(6): 631-640.
[19] Dickson R P, Erb-Downward J R, Martinez F J, et al. The
Microbiome and the Respiratory Tract[J]. Annual Review of
Physiology, 2016, 78: 481-504.
[20] Venkataraman A, Bassis C M, Beck J M, et al.
Application of a neutral community model to assess
structuring of the human lung microbiome[J]. mBio, 2015,
6(1): 10-1128.
[21] Willner D, Haynes M R, Furlan M, et al. Spatial
distribution of microbial communities in the cystic fibrosis
lung[J]. ISME Journal, 2012, 6(2): 471-474.
[22] Donaldson G P, Lee S M, Mazmanian S K. Gut
biogeography of the bacterial microbiota[J]. Nature Reviews
Microbiology, 2015, 14(1): 20-32.
[23] Kovachev S. Defence factors of vaginal lactobacilli[J].
Critical Reviews in Microbiology, 2018, 44(1): 31-39.
[24] Aroutcheva A A, Simoes J A, Faro S. Antimicrobial
2025 年第 12 期
6
protein produced by vaginal Lactobacillus acidophilus that
inhibits gardnerella vaginalis[J]. Infectious Diseases in
Obstetrics and Gynecology, 2001, 9(1): 33-39.
[25] Al-Megrin W A, Mohamed S H, Saleh M M, et al.
Preventive role of probiotic bacteria against gastrointestinal
diseases in mice caused by Giardia lamblia[J]. Bioscience
Reports, 2021, 41(2): BSR20204114.
[26] Li T, Liu Z, Zhang Z, et al. Comparative analysis of the
vaginal microbiome of Chinese women with Trichomonas
vaginalis and mixed infection[J]. Microbial Pathogenesis,
2021, 154: 104790.
[27] Ngobese B, Singh R, Han K S S, et al. Detection of
metronidazole resistance in Trichomonas vaginalis using
uncultured vaginal swabs[J]. Parasitology Research, 2022,
121(8): 2421-2432.
[28] Saito-Nakano Y, Umeki Y, Shimokawa C, et al.
Prevalence and metronidazole resistance of Trichomonas
vaginalis among Japanese women in 2021[M]//IJID Regions:
Vol 7. IJID Reg, 2023.
[29] Phukan N, Parsamand T, Brooks A E S, et al. The
adherence of Trichomonas vaginalis to host ectocervical
cells is influenced by lactobacilli[J]. Sexually Transmitted
Infections, 2013, 89(6): 455-459.
[30] Phukan N, Brooks A E S, Simoes-Barbosa A. A cell
surface aggregationpromoting factor from Lactobacillus
gasseri contributes to inhibition of Trichomonas vaginalis
adhesion to human vaginal ectocervical cells[J]. Infection
and Immunity, 2018, 86(8): 10-1128.
[31] Abusleme L, Dupuy A K, Dutzan N, et al. The
subgingival microbiome in health and periodontitis and its
relationship with community biomass and inflammation[J].
ISME Journal, 2013, 7(5): 1016-1025.
[32] Ji F, Zhang D, Shao Y, et al. Changes in the diversity
and composition of gut microbiota in pigeon squabs infected
with Trichomonas gallinae[J]. Scientific Reports, 2020, 10(1):
1-13.
[33] Bierlein M, Hedgespeth B A, Azcarate-Peril M A, et
al. Dysbiosis of fecal microbiota in cats with naturally
occurring and experimentally induced Tritrichomonas foetus
infection[J]. PLoS ONE, 2021, 16: 246957.
[34] Zhang H, Yu Y, Li J, et al. Changes of gut microbiota in
colorectal cancer patients with Pentatrichomonas hominis
infection[J]. Frontiers in Cellular and Infection Microbiology,
2022, 12: 961974.
[35] Yaseen A, Mahafzah A, Dababseh D, et al. Oral
Colonization by Entamoeba gingivalis and Trichomonas
tenax: A PCR-Based Study in Health, Gingivitis, and
Periodontitis[J]. Frontiers in Cellular and Infection
Microbiology, 2021, 11: 782805.
[36] Swanson K S, Gibson G R, Hutkins R, et al. The
International Scientific Association for Probiotics and
Prebiotics (ISAPP) consensus statement on the definition and
scope of synbiotics[J]. Nature Reviews Gastroenterology and
Hepatology, 2020, 17(11): 687-701.
[37] Rijkers G T, De Vos W M, Brummer R J, et al. Health
benefits and health claims of probiotics: Bridging science and
marketing[J]. British Journal of Nutrition, 2011, 106(9): 1291-
1296.
[38] Pais P, Almeida V, Yilmaz M, et al. Saccharomyces
boulardii: What makes it tick as successful probiotic?[J].
Journal of Fungi, 2020, 6(2): 1-15.
[39] Szajewska H, Skórka A, Ruszczyński M, et al. Meta￾analysis: Lactobacillus GG for treating acute diarrhoea in
children[J]. Alimentary Pharmacology and Therapeutics,
2007, 25(8): 871-881.
[40] Szajewska H, Skórka A, Ruszczyński M, et al. Meta￾Analysis: Lactobacillus GG for treating acute gastroenteritis
in children - Updated analysis of randomised controlled
trials[J]. Alimentary Pharmacology and Therapeutics, 2013,
38(5): 467-476.
[41] 苟翠娥 , 仲玉梅 . 乳酸杆菌活菌制剂治疗阴道炎的效
果分析 [J]. 中国社区医师 , 2023, 39(06): 19–21.
[42] Cadore P S, Walcher D L, De Sousa N F G C, et al.
Protective effect of the probiotic Lactobacillus acidophilus
ATCC 4356 in BALB/c mice infected with Toxocara canis[J].
Revista do Instituto de Medicina Tropical de Sao Paulo, 2021,
63: 1-6.
[43] Almallah T M, Khedr S I, El Nouby K A, et al. The
synergetic potential of Lactobacillus delbrueckii and
Lactobacillus fermentum probiotics in alleviating the
outcome of acute toxoplasmosis in mice[J]. Parasitology
Research, 2023, 122(4): 927-937.
[44] Mona Gaber, Lamia Ahmed A Galal, Haiam Mohamed
Mahmoud Farrag, et al.. The Effects of Commercially
Available Syzygium aromaticum, Anethum graveolens,
Lactobacillus acidophilus LB , and Zinc as Alternatives
Therapy in Experimental Mice Challenged with
Cryptosporidium parvum [J]. Infection and Drug Resistance,
2022, 15: 171-82.
[45] Anjum N, Maqsood S, Masud T, et al. Lactobacillus
acidophilus: Characterization of the Species and Application
in Food Production[J]. Critical Reviews in Food Science and
2025 年第 12 期
7
Nutrition, 2014, 54(9): 1241-1251.
[46] Mitall B K, Garg S K. Anticarcinogenic, hypocholesterolemic,
and antagonistic activities of lactobacillus acidophilus[J]. Critical
Reviews in Microbiology, 1995, 21(3): 175-214.
[47] Fernandes C F, Shahani K M, Staudinger W L, et al.
Effect of Lactobacillus Acidophilus on Growth of Ehrlich
Ascites Tumor in Swiss Mice[J]. Journal of Nutritional
Medicine, 1991, 2(1): 25-34.
[48] Hu T, Wang H, Xiang C, et al. Preventive effect of
lactobacillus acidophilus XY27 on DSS-induced ulcerative
colitis in mice[J]. Drug Design, Development and Therapy,
2020, 14: 5645-5657.
[49] Shen S, Ren F F, Qin H, et al. Lactobacillus acidophilus
NCFM and Lactiplantibacillus plantarum Lp-115 inhibit
Helicobacter pylori colonization and gastric inflammation
in a murine model[J]. Frontiers in Cellular and Infection
Microbiology, 2023, 13: 1196084.
[50] Kang Y, Kang X, Yang H, et al. Lactobacillus
acidophilus ameliorates obesity in mice through modulation
of gut microbiota dysbiosis and intestinal permeability[J].
Pharmacological Research, 2022, 175: 106020.
[51] Zhang L, Ma H, Kulyar M F E. A, et al. Complete
genome analysis of Lactobacillus fermentum YLF016 and
its probiotic characteristics[J]. Microbial Pathogenesis, 2022,
162: 105212.
[52] De Gregorio A, Serafino A, Krasnowska E K, et al.
Protective Effect of Limosilactobacillus fermentum ME-3
against the Increase in Paracellular Permeability Induced by
Chemotherapy or Inflammatory Conditions in Caco-2 Cell
Models[J]. International Journal of Molecular Sciences, 2023,
24(7): 6225.
[53] Falah F, Vasiee A, Behbahani B A, et al. Evaluation
of adherence and anti-infective properties of probiotic
Lactobacillus fermentum strain 4-17 against Escherichia
coli causing urinary tract infection in humans[J]. Microbial
Pathogenesis, 2019, 131: 246-253.
[54] 蒋晓晗 , 阳田恬 , 李金转 , 等 . 加氏乳杆菌的特性与生
物学功能及其生产应用 [J]. 加氏乳杆菌的特性与生物学功
能及其生产应用 [J]. 饲料工业 , 2023, 44(06): 96-100.
[55] Baltov K, Dimitrov Z. Probiotic and cultural
characteristic of strain lactobacillus gasseri 4/13 of human
origin[J]. Biotechnology and Biotechnological Equipment,
2014, 28(6): 1084-1088.
[56] Carroll I M, Andrus J M, Bruno-Bárcena J M, et al. Antiinflammatory properties of Lactobacillus gasseri expressing
manganese superoxide dismutase using the interleukin
10-deficient mouse model of colitis[J]. American Journal of
Physiology - Gastrointestinal and Liver Physiology, 2007,
293(4): 729-38.
[57] Quigley L, Coakley M, Alemayehu D, et al. Lactobacillus
gasseri APC 678 reduces shedding of the pathogen
Clostridium difficile in a murine Model[J]. Frontiers in
Microbiology, 2019, 10: 273.
[58] Liang J R, Deng H, Hu C Y, et al. Vitality, fermentation,
aroma profile, and digestive tolerance of the newly selected
Lactiplantibacillus plantarum and Lacticaseibacillus
paracasei in fermented apple juice[J]. Frontiers in Nutrition,
2022, 9: 1045347.
[59] Zhou Y, Gong W, Xu C, et al. Probiotic assessment and
antioxidant characterization of Lactobacillus plantarum
GXL94 isolated from fermented chili[J]. Frontiers in
Microbiology, 2022, 13: 997940.
[60] Negm El-Dein A, Ezzat A, Aly H F, et al. Lactobacillusfermented yogurt exerts hypoglycemic, hypocholesterolemic,
and anti-inflammatory activities in STZ-induced diabetic
Wistar rats[J]. Nutrition Research, 2022, 108: 22-32.
[61] Yang X, Peng Z, He M, et al. Screening, probiotic
properties, and inhibition mechanism of a Lactobacillus
antagonistic to Listeria monocytogenes[J]. Science of the
Total Environment, 2024, 906: 167587.
[62] Butrungrod W, Chaiyasut C, Makhamrueang N, et al.
Postbiotic Metabolite of Lactiplantibacillus plantarum PD18
against Periodontal Pathogens and Their Virulence Markers
in Biofilm Formation[J]. Pharmaceutics, 2023, 15(5): 1419.
[63] You T, Zhao Y, Liu S, et al. Lactiplantibacillus
plantarum P101 Attenuated Cyclophosphamide-Induced
Liver Injury in Mice by Regulating the Nrf2/ARE Signaling
Pathway[J]. International Journal of Molecular Sciences,
2023, 24(17): 13424.
[64] Gaziano R, Sabbatini S, Roselletti E, et al. Saccharomyces
cerevisiae-Based Probiotics as Novel Antimicrobial Agents
to Prevent and Treat Vaginal Infections[J]. Frontiers in
Microbiology, 2020, 11: 718.
[65] Fernandez-Pacheco P, Arévalo-Villena M, Bevilacqua A,
et al. Probiotic characteristics in Saccharomyces cerevisiae
strains: Properties for application in food industries[J]. Lwt,
2018, 97: 332-340.
[66] Kelesidis T, Pothoulakis C. Efficacy and safety of
the probiotic Saccharomyces boulardii for the prevention
and therapy of gastrointestinal disorders[J]. Therapeutic
Advances in Gastroenterology, 2012, 5(2): 111-125.
[67] Mansour-Ghanaei F, Dehbashi N, Yazdanparast K,et al. Efficacy of saccharomyces boulardii with antibiotics
in acute amoebiasis[J]. World Journal of Gastroenterology,
2003, 9(8): 1832-1833.
[68] Dinleyici E C, Eren M, Dogan N, et al. Clinical efficacy
of Saccharomyces boulardii or metronidazole in symptomatic
children with Blastocystis hominis infection[J]. Parasitology
Research, 2011, 108(3): 541-545.
[69] Hill C, Guarner F, Reid G, et al. Expert consensus
document: The international scientific association for
probiotics and prebiotics consensus statement on the scope
and appropriate use of the term probiotic[J]. Nature Reviews
Gastroenterology and Hepatology, 2014, 11(8): 506-514.
[70] De Preter V, Vanhoutte T, Huys G, et al. Baseline
microbiota activity and initial bifidobacteria counts influence
responses to prebiotic dosing in healthy subjects[J]. Alimentary
Pharmacology and Therapeutics, 2008, 27(6): 504-513.
[71] Marrouche N, Lancaster N, Grindlay D J C, et al.
What’ s new in atopic eczema? An analysis of systematic
reviews published in 2019. Part 2: treatment[J]. Clinical and
Experimental Dermatology, 2021, 46(7): 1211-1215.
[72] Moro G, Arslanoglu S, Stahl B, et al. A mixture of
prebiotic oligosaccharides reduces the incidence of atopic
dermatitis during the first six months of age[J]. Archives of
Disease in Childhood, 2006, 91(10): 814-819.
[73] Mattia A, Merker R. Regulation of probiotic substances
as ingredients in foods: Premarket approval or “generally
recognized as safe” notification[M]//Clinical Infectious
Diseases. 2008: S115-S118.
[74] Herbrecht R, Nivoix Y. Saccharomyces cerevisiae
fungemia: An adverse effect of Saccharomyces boulardii
probiotic administration[J]. Clinical Infectious Diseases,
2005, 40(11): 1635-1637.
[75] De Groote M A, Frank D N, Dowell E, et al.
Lactobacillus rhamnosus GG bacteremia associated with
probiotic use in a child with short gut syndrome[J]. Pediatric
Infectious Disease Journal, 2005, 24(3): 278-280.
[76] Venkatesan T. Probiotic prophylaxis in predicted severe
acute pancreatitis: A randomised, double-blind, placebocontrolled trial[J]. Nutrition in Clinical Practice, 2008, 23(6):
662-663.
[77] Kuitunen M, Kukkonen K, Savilahti E. Pro- and
prebiotic supplementation induces a transient reduction in
hemoglobin concentration in infants[J]. Journal of Pediatric
Gastroenterology and Nutrition, 2009, 49(5): 626-630.